NEuroCOUGH慢性咳登记:一个泛欧洲观测研究的协议
Peter S P Cho1,2, Surinder S Birring1,2, Clíona McDowell3
1Department of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
ERJ open research
|September 24, 2025
概括
NEuroCOUGH注册表是欧洲首个前性研究,收集慢性咳患者的数据. 这一倡议旨在通过分析全面的临床和生理数据来改善慢性咳的理解和治疗.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
- 流行病学 流行病学
背景情况:
- 慢性咳是一种普遍且具有挑战性的临床问题.
- 咳管理现有的专业知识在欧洲各地分散.
- 需要整合数据,以便更深入地了解慢性咳.
研究的目的:
- 建立第一个全欧洲慢性咳前性观察登记册.
- 收集全面的临床,生理和生物数据.
- 提高对慢性咳现象型,疾病负担和自然史的理解.
主要方法:
- 招募成年患者 (≥18岁) 咳>8周持续时间.
- 现在的/最近的吸烟者和那些有阻塞性螺旋计的人除外.
- 在13个欧洲地点进行36个月的前性观察研究,每12个月进行36个月的随访.
主要成果:
- 建立了NeuroCOUGH注册表,作为一个重要的临床和研究资源.
- 正在收集有关慢性咳,其影响和结果的全面数据.
- 该研究的目标是到2026年招募2500名患者.
结论:
- 该NEuroCOUGH注册表将促进对慢性咳的理解.
- 它将促进专门的咳诊所和临床试验基础设施的发展.
- 最终,这一倡议旨在改善慢性咳患者的护理.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Observational Studies
10.7K
Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
10.7K
Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Study Designs in Epidemiology
897
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
897
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K


